213 related articles for article (PubMed ID: 2988125)
1. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
Young JF; Hockmeyer WT; Gross M; Ballou WR; Wirtz RA; Trosper JH; Beaudoin RL; Hollingdale MR; Miller LH; Diggs CL
Science; 1985 May; 228(4702):958-62. PubMed ID: 2988125
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
[TBL] [Abstract][Full Text] [Related]
4. Development of a sporozoite malaria vaccine.
Nussenzweig V; Nussenzweig RS
Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
[No Abstract] [Full Text] [Related]
5. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
[TBL] [Abstract][Full Text] [Related]
6. The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trials.
Caspers P; Gentz R; Matile H; Pink JR; Sinigaglia F
Mol Biochem Parasitol; 1989 Jun; 35(2):185-9. PubMed ID: 2671723
[No Abstract] [Full Text] [Related]
7. Recent efforts in the development of a sporozoite vaccine against human malaria.
Hockmeyer WT; Dame JB
Adv Exp Med Biol; 1985; 185():233-45. PubMed ID: 3907309
[TBL] [Abstract][Full Text] [Related]
8. DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope.
Enea V; Ellis J; Zavala F; Arnot DE; Asavanich A; Masuda A; Quakyi I; Nussenzweig RS
Science; 1984 Aug; 225(4662):628-30. PubMed ID: 6204384
[TBL] [Abstract][Full Text] [Related]
9. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.
Dame JB; Williams JL; McCutchan TF; Weber JL; Wirtz RA; Hockmeyer WT; Maloy WL; Haynes JD; Schneider I; Roberts D
Science; 1984 Aug; 225(4662):593-9. PubMed ID: 6204383
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.
Hollingdale MR; Ballou WR; Aley SB; Young JF; Pancake S; Miller LH; Hockmeyer WT
Exp Parasitol; 1987 Jun; 63(3):345-51. PubMed ID: 2438152
[TBL] [Abstract][Full Text] [Related]
11. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
[TBL] [Abstract][Full Text] [Related]
12. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
13. Malaria vaccine against sporozoites?
Nussenzweig V; Nussenzweig RS
Ann Inst Pasteur Immunol (1985); 1985; 136D(3):301-12. PubMed ID: 3913382
[TBL] [Abstract][Full Text] [Related]
14. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
Hoffman SL; Oster CN; Plowe CV; Woollett GR; Beier JC; Chulay JD; Wirtz RA; Hollingdale MR; Mugambi M
Science; 1987 Aug; 237(4815):639-42. PubMed ID: 3299709
[TBL] [Abstract][Full Text] [Related]
15. Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites.
Nussenzweig V; Nussenzweig R
Ciba Found Symp; 1986; 119():150-63. PubMed ID: 2426050
[TBL] [Abstract][Full Text] [Related]
16. The malaria sporozoite vaccine: parasitology's brave new world.
Spriggs DR
J Infect Dis; 1985 Sep; 152(3):655-6. PubMed ID: 2411830
[No Abstract] [Full Text] [Related]
17. The main obstacle to a malaria vaccine: the malaria parasite.
Miller LH; Good MF
Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection.
Webster HK; Brown AE; Chuenchitra C; Permpanich B; Pipithkul J
J Clin Microbiol; 1988 May; 26(5):923-7. PubMed ID: 2454941
[TBL] [Abstract][Full Text] [Related]
19. Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.
Barr PJ; Gibson HL; Enea V; Arnot DE; Hollingdale MR; Nussenzweig V
J Exp Med; 1987 Apr; 165(4):1160-71. PubMed ID: 3549959
[TBL] [Abstract][Full Text] [Related]
20. Molecular approaches to malaria vaccines.
Godson GN
Sci Am; 1985 May; 252(5):52-9. PubMed ID: 2408333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
